Valuation: Krka, d. d.

Market Cap 7.87B 9.19B 7.34B 6.74B 12.66B 880B 12.91B 87.13B 33.97B 441B 34.52B 33.77B 1,460B P/E 2026 *
18.7x
P/E 2027 * 17.9x
Enterprise Value 7.2B 8.41B 6.72B 6.17B 11.59B 805B 11.81B 79.72B 31.07B 403B 31.58B 30.9B 1,335B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.13x
Free-Float
74.74%
Yield 2026 *
3.85%
Yield 2027 * 3.94%
1 week+0.19%
Current month+0.19%
1 month-3.17%
3 months+1.17%
6 months+6.56%
Current year+28.08%
1 week 258.5
Extreme 258.5
260.5
1 month 257
Extreme 257
264
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.19%+30.00%+147.62% 9.18B
+0.21%-2.06%+17.05%+67.77% 47.69B
+4.52%+2.86%+54.54%+133.29% 39.96B
+1.13%-1.71%-7.16%+16.31% 12.02B
+0.29%-8.07%+11.95%+70.98% 11.53B
-0.39%-1.15%+19.93%+39.54% 7.53B
+0.87%+2.71%+44.53%-10.48% 7.29B
+3.85%+1.87%+19.89%+204.48% 6.63B
+2.65%-2.15%-31.66%+24.03% 5.57B
-1.06%+3.32%+35.34%+106.71% 4.83B
Average +1.21%-1.28%+19.44%+80.02% 15.22B
Weighted average by Cap. +1.62%-1.93%+25.76%+86.41%

Financials

2026 *2027 *
Net sales 2.16B 2.53B 2.02B 1.85B 3.48B 242B 3.55B 23.95B 9.33B 121B 9.49B 9.28B 401B 2.29B 2.68B 2.14B 1.96B 3.69B 256B 3.76B 25.35B 9.88B 128B 10.05B 9.83B 425B
Net income 427M 498M 398M 365M 686M 47.68B 700M 4.72B 1.84B 23.89B 1.87B 1.83B 79.11B 449M 524M 419M 384M 722M 50.14B 736M 4.97B 1.94B 25.13B 1.97B 1.92B 83.19B
Net Debt -670M -783M -625M -574M -1.08B -74.88B -1.1B -7.42B -2.89B -37.52B -2.94B -2.87B -124B -708M -827M -660M -606M -1.14B -79.09B -1.16B -7.83B -3.05B -39.64B -3.1B -3.04B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
20/08/26 €260.00 0.00% 4,062
19/08/26 €260.00 0.00% 4,098
18/08/26 €260.00 0.00% 5,820
17/08/26 €260.00 +0.58% 2,946
14/08/26 €258.50 -0.58% 971
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
245.65EUR
Spread / Average Target
-5.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock